BRCA1 alleviates inflammation, oxidative stress, and ovarian granulosa cell apoptosis by inhibiting endoplasmic reticulum stress, thereby ameliorating polycystic ovary syndrome. [PDF]
Huang X +7 more
europepmc +1 more source
Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study. [PDF]
Yang R +18 more
europepmc +1 more source
Ovarian follicular density in women with BRCA1 and BRCA2 mutations: new insights into the negative impact on ovarian reserve. [PDF]
Maletta M +11 more
europepmc +1 more source
Unique perspectives about men's awareness of BRCA1/2 genetic testing in primary care. [PDF]
Andrews CS +4 more
europepmc +1 more source
Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer. [PDF]
Chen L, He S.
europepmc +1 more source
Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant.
Regev-Sadeh S +9 more
europepmc +1 more source
Multi-target modulation of the homologous recombination pathway by resveratrol promotes DNA damage repair in POI: integrated network pharmacology, molecular dynamics simulation, and experimental validation. [PDF]
Yu Z +13 more
europepmc +1 more source
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Germline Mutations in Vietnamese Patients With Triple-Negative Breast Cancer. [PDF]
Toan TT +5 more
europepmc +1 more source
Roles of ADP-Ribosyltransferases in Cancer. [PDF]
Veilleux M, Nguyen A, Cao C, Shi Y.
europepmc +1 more source

